| Grant |
AMPLIFICATION OF ANTIVIRAL INNATE IMMUNITY BY SUPPRESSOR OF VIRUS RNA (svRNA) |
$499,999 |
Cleveland |
OH |
0 |
0 |
| Grant |
AUTOIMMUNE INDUCED BREAST FAILURE AS A STRATEGY FOR BREAST CANCER VACCINATION |
$325,775 |
Cleveland |
OH |
1 |
0 |
| Grant |
Biomarkers for Complications in Type 1 Diabetes (DCCT/EDIC) |
$697,154 |
Cleveland |
OH |
0 |
0 |
| Grant |
Cell Interactions in the Inflamed Intestinal Mucosa |
$107,974 |
Cleveland |
OH |
0 |
0 |
| Grant |
CELLULAR AND BIOCHEMICAL STUDIES OF MYOSIN ASSEMBLY IN DICTYOSTELIUM |
$84,074 |
Cleveland |
OH |
0 |
0 |
| Grant |
DBS OF THE PEDUNCULOPONTINE NUCLEUS IN PARKINSONIAN PRIMATE |
$375,727 |
Cleveland |
OH |
0 |
0 |
| Grant |
ER-TO-GOLGI TRANSPORT OF COAGULATION FACTORS V AND VIII |
$188,455 |
Cleveland |
OH |
1 |
0 |
| Grant |
ER-TO-GOLGI TRANSPORT OF COAGULATION FACTORS V AND VIII |
$13,188 |
Cleveland |
OH |
0 |
0 |
| Grant |
Ethics of Control and Consent in Brain Stimulation for Parkinson Disease |
$415,326 |
Cleveland |
OH |
0 |
-1 |
| Grant |
GENETICS OF ATRIAL FIBRILLATION |
$250,814 |
Cleveland |
OH |
0 |
0 |
| Grant |
GENETICS OF ATRIAL FIBRILLATION |
$37,178 |
Cleveland |
OH |
1 |
0 |
| Grant |
Hemodialysis Fistula Maturation Consortium Data Coordinating Center |
$542,808 |
Cleveland |
OH |
0 |
2 |
| Grant |
Homocysteine:Vascular Biochemistry and Metabolism |
$18,212 |
Cleveland |
OH |
0 |
0 |
| Grant |
Imaging Inflammation in Asthma |
$246,324 |
Cleveland |
OH |
0 |
0 |
| Grant |
Improving CBF through direct control of CSF pulsations |
$799,298 |
Cleveland |
OH |
0 |
0 |
| Grant |
INFORMED CONSENT IN PEDIATRIC PHASE I CANCER TRIALS |
$160,519 |
Cleveland |
OH |
0 |
0 |
| Grant |
INITIATING EVENTS IN AMD: AN ANIMAL MODEL FOR THE HUMAN DISEASE |
$323,623 |
Cleveland |
OH |
0 |
0 |
| Grant |
MAGNETOPHORETIC CELL SORTING AND ANALYSIS |
$128,397 |
Cleveland |
OH |
0 |
0 |
| Grant |
MECHANISM OF BASOPHIL MEDIATED IMMUNE MODULATION |
$191,120 |
Cleveland |
OH |
1 |
0 |
| Grant |
Molecular Elucidation of Integrin Signaling |
$78,772 |
Cleveland |
OH |
0 |
0 |